Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective
2020 ◽
Vol 18
(1)
◽
2005 ◽
Vol 59
(9)
◽
pp. 1011-1016
◽
2017 ◽
Vol 19
(5)
◽
pp. 661-669
◽
2019 ◽
Vol 43
(3)
◽
pp. 219-224
◽
2013 ◽
Vol 16
(3)
◽
pp. 381-390
◽
Keyword(s):